The Strategic Questions Reshaping the CDMO Map
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
False
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 12, 2026
8 min read
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
October 7, 2026
1 min read
Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization
September 21, 2026
5 min read
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
False
Affiliations:
Specialties:
Areas of Expertise: